Sep 6, 2024 · SpeeDx utilises PlexZyme® technology, de-coupling the detection probe from the primer sequence to produce universal probes which can be used across our entire product portfolio. Our …

Founded in 2009, SpeeDx specializes in molecular diagnostic solutions that go beyond simple detection to offer comprehensive information for improved patient management.

Founded in 2009, SpeeDx is an Australian-based private company with offices in London and the US, and distributors across Europe. SpeeDx employs a growing number of team members across our …

SpeeDx specializes in molecular diagnostic solutions that go beyond simple detection to offer comprehensive information for improved patient management.

PlexZyme® technology offers high performance and reliable qPCR detection and is the driver behind the entire SpeeDx product portfolio. During PlexZyme® qPCR, primers amplify target nucleic acid …

USA – SpeeDx Inc. © Copyright 2022 SpeeDx Pty. Ltd. | ABN: 46135095886 | Terms and Conditions | Patents | Modern Slavery Statement | Privacy Policy | ISO 13485:2016 certificate

Please contact SpeeDx for information about offering SpeeDx diagnostics in your clinic or for a list of current pathology clinics where SpeeDx testing is available.

Improve productivity and streamline laboratory workflow with SpeeDx automation solutions. Flexible operation and programming for sample extraction preparation and/or qPCR reaction set-up.

Please contact SpeeDx for information about offering SpeeDx diagnostics in your clinic or for a list of current pathology clinics where SpeeDx testing is available.

SpeeDx, a leading global molecular diagnostics company, offers an exceptional opportunity for an ambitious PhD candidate to drive a commercially focused research project with significant potential …